Related Experiment Video

Updated: Aug 9, 2026

Induction and Assessment of Class Switch Recombination in Purified Murine B Cells
09:49

Induction and Assessment of Class Switch Recombination in Purified Murine B Cells

Published on: August 14, 2010

Regulation of Ku expression in normal murine B cells by stimuli that promote switch recombination

P Zelazowski1, E E Max, M R Kehry

  • 1Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|September 23, 1997
PubMed

Insights

This study shows that B cell activation by specific stimuli increases nuclear Ku expression, a key protein in DNA repair. This rise in Ku occurs before switch recombination, suggesting it regulates this crucial immune process.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • DNA-dependent protein kinase (DNA-PK), associated with the Ku heterodimer (Ku70/Ku86), is involved in DNA repair and V(D)J recombination.
  • Switch recombination is a critical process in adaptive immunity, particularly in B cells.

Purpose of the Study:

  • To investigate whether stimuli that promote switch recombination also induce the expression of Ku.
  • To determine the role of Ku expression in regulating switch recombination in B cells.

Main Methods:

  • B cells were cultured with various stimuli known to induce switch recombination.
  • Nuclear Ku levels were assessed using methods such as Western blotting or immunofluorescence.
  • The timing of Ku expression changes relative to switch recombination events was analyzed.

Main Results:

  • Resting B cells exhibit low nuclear Ku levels.
  • Combined IL-4 and CD40 stimulation significantly up-regulated Ku expression within 24 hours, preceding switch recombination by approximately two days.
  • Dextran-conjugated anti-IgD antibodies strongly induced Ku expression, with variable enhancement by IL-5 but not IL-4.

Conclusions:

  • Ku expression in B cells is dynamically regulated by specific immune stimuli.
  • Changes in nuclear Ku expression levels appear to be a regulatory mechanism for switch recombination.
  • This finding provides insight into the molecular control of immunoglobulin class switch recombination.

More Related Videos

Recombinant Retroviral Production and Infection of B Cells09:19

Recombinant Retroviral Production and Infection of B Cells

Published on: February 19, 2011

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp111:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Crossing Over01:30

Crossing Over

Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I, duplicated...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...